Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Oligometastatic Lung Tumor”

64 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 64 results

Testing effectiveness (Phase 2)Study completedNCT01725165
What this trial is testing

Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer

Who this might be right for
Recurrent Lung Non-Small Cell CarcinomaStage IV Non-Small Cell Lung Cancer AJCC v7
M.D. Anderson Cancer Center 85
Testing effectiveness (Phase 2)UnknownNCT05754736
What this trial is testing

Clinical Study of Ametinib Combined With Bevacizumab in First-line Treatment of Advanced NSCLC With EGFR-mutations.

Who this might be right for
Non-small Cell Lung Cancer
The Second Affiliated Hospital of Shandong First Medical University 50
Testing effectiveness (Phase 2)UnknownNCT03119519
What this trial is testing

Local Non-salvage Radiotherapy for Synchronous Oligometastatic Non-small-cell Lung Cancer.

Who this might be right for
Stage IV Non-small Cell Lung Cancer
Southern Medical University, China 148
Testing effectiveness (Phase 2)Looking for participantsNCT03808337
What this trial is testing

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Who this might be right for
Triple Negative Breast CancerNon Small Cell Lung CancerMetastatic Breast Cancer+1 more
Memorial Sloan Kettering Cancer Center 145
Not applicableStudy completedNCT02805530
What this trial is testing

Radical Treatment of Synchronous Oligometastatic Non-Small Cell Lung Carcinoma

Who this might be right for
Carcinoma, Non-Small-Cell LungSynchronous Neoplasms
Instituto Nacional de Cancerologia de Mexico 36
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06851819
What this trial is testing

Tislelizumab in Combination with Chemotherapy ± Radiotherapy for Extensive-Stage Oligometastatic Small Cell Lung Cancer.

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Hebei Medical University Fourth Hospital 64
Not applicableActive Not RecruitingNCT07389642
What this trial is testing

Brain Oligometastasis in NSCLC

Who this might be right for
Brain OligometastaticNon-small Cell Lung Cancer
University Hospital, Bordeaux 46
Not applicableUnknownNCT04758481
What this trial is testing

Consolidation Conventional Radiotherapy + Stereotactic Body Radiotherapy at 3 Months After First-line Chemotherapy in Stage IV Oligometastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
University Hospital Ostrava 20
Testing effectiveness (Phase 2)UnknownNCT04255836
What this trial is testing

Durvalumab Combined With Chemotherapy and Stereotactic Body Radiotherapy (SBRT) in Patients With Oligometastatic Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Zhejiang Cancer Hospital 35
Testing effectiveness (Phase 2)Ended earlyNCT00776100
What this trial is testing

Radiation Therapy or Observation After Chemotherapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 3
Testing effectiveness (Phase 2)UnknownNCT03557411
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Hypofraction Radiotherapy in Patients With NSCLC

Who this might be right for
Non-Small-Cell Lung Cancer
Shandong Cancer Hospital and Institute 42
Large-scale testing (Phase 3)Looking for participantsNCT06840782
What this trial is testing

First-line Immunotherapy-based Standard of Care and Local Ablative Treatments for Oligometastatic Non-small Cell Lung Cancer Patients.

Who this might be right for
Oligometastatic Non-small Cell Lung Cancer (NSCLC)
Gustave Roussy, Cancer Campus, Grand Paris 124
Not applicableWithdrawnNCT01325753
What this trial is testing

Cryotherapy in Treating Patients With Lung Cancer That Has Spread to the Other Lung or Parts of the Body

Who this might be right for
Advanced Malignant MesotheliomaExtensive Stage Small Cell Lung CancerLung Metastases+4 more
Wake Forest University Health Sciences
Testing effectiveness (Phase 2)UnknownNCT02975609
What this trial is testing

Phase II Trial of SBRT Compared With Conventional Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer

Who this might be right for
NSCLC
Shanghai Chest Hospital 100
Not applicableLooking for participantsNCT07325864
What this trial is testing

Molecular Phenotyping of Primitive Lung Cancer and Metastatic Site

Who this might be right for
NSCLCLung Cancer (Diagnosis)
European Institute of Oncology 25
Not applicableLooking for participantsNCT07441941
What this trial is testing

Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup

Who this might be right for
Oligometastatic Lung TumorNSCLC (Non-small Cell Lung Cancer)SBRT
Institut du Cancer de Montpellier - Val d'Aurelle 190
Large-scale testing (Phase 3)Looking for participantsNCT05278052
What this trial is testing

Standard Maintenance Therapy (SMT) vs Local Consolidative Radiation Therapy and SMT in OM-NSCLC

Who this might be right for
Oligometastatic DiseaseMetastatic Non Small Cell Lung Cancer
Tata Memorial Hospital 190
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06946849
What this trial is testing

Second-line Regimen Combined With Radiotherapy Versus Without Radiotherapy in Patients With Locally Advanced/Oligometastatic ICC After Failure of First-line Treatment：an Open-label, Randomized, Controlled Phase II Clinical Study

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)
Shanghai Zhongshan Hospital 76
Testing effectiveness (Phase 2)UnknownNCT04486287
What this trial is testing

Sintilimab After Stereotactic Ablation Brachytherapy for Refractory Oligometastatic Non-Small Cell Lung Cancer

Who this might be right for
OligometastasisLung Neoplasms
Tianjin Medical University Second Hospital 44
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07777614
What this trial is testing

OPTIMISE Lung SABR

Who this might be right for
Non Small Cell Lung Cancer
Cancer Trials Ireland 208
Next Page